Edgewise Therapeutics, Inc. EWTX Proceeds from maturities of investments
Proceeds from maturities of investments at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfHeldToMaturitySecurities.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s proceeds from maturities of investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s proceeds from maturities of investments?
- Edgewise Therapeutics, Inc. (EWTX) reported proceeds from maturities of investments of $3.97M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s proceeds from maturities of investments changed year-over-year?
- Edgewise Therapeutics, Inc.'s proceeds from maturities of investments decreased by 73.6% year-over-year, from $15M to $3.97M.
- What does proceeds from maturities of investments mean?
- This metric captures the cash inflows generated from the sale or maturity of debt securities classified as held-to-maturity. It provides insight into the company's liquidity management and the conversion of its investment portfolio into cash. High activity here indicates active treasury management or the liquidation of assets to fund ongoing operational or capital requirements.